Back to Search
Start Over
High serum complement component C4 as a unique predictor of unfavorable outcomes in diabetic stroke.
- Source :
- Metabolic Brain Disease; Dec2021, Vol. 36 Issue 8, p2313-2322, 10p
- Publication Year :
- 2021
-
Abstract
- Previous studies demonstrated that diabetic stroke patients had a poor prognosis and excess complement system activation in the peripheral blood. In this study, the association of serum complement levels with the prognosis of diabetic stroke was examined. Patients with acute ischemic stroke were recruited and were divided into two groups according to their history of diabetes. Baseline data on the admission, including C3 and C4 were collected. Neurologic function at discharge was the primary outcome and was quantified by the National Institutes of Health Stroke Scale (NIHSS). A total of 426 patients with acute ischemic stroke (116 diabetic strokes and 310 non-diabetic strokes) were recruited in this study. There were significant differences between the two groups in hypertension, coronary disease, triglyceride, high-density lipoprotein cholesterol, fasting blood sugar, C4, and mortality rates. Furthermore, the values of complement protein levels were divided into tertiles. In the diabetic stroke group, serum C4 level at the acute phase in the upper third was independently associated with NIHSS score at discharge and concurrent infection. These associations were not significant in non-diabetic stroke. High serum C4 level at admission, as a unique significant predictor, was associated with unfavorable clinical outcomes in the diabetic stroke, independently of traditional risk factors. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 08857490
- Volume :
- 36
- Issue :
- 8
- Database :
- Complementary Index
- Journal :
- Metabolic Brain Disease
- Publication Type :
- Academic Journal
- Accession number :
- 153497432
- Full Text :
- https://doi.org/10.1007/s11011-021-00834-0